4.7 Article

Inflammation and airway function in the lung periphery of patients with stable asthma

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 125, Issue 3, Pages 611-616

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2009.10.053

Keywords

Small airways; exhaled nitric oxide; stable asthma; inflammation

Funding

  1. Fund for Scientific Research Flanders
  2. European Space Agency

Ask authors/readers for more resources

Background: An important role for exhaled nitric oxide (NO) measurement could be in the distinction between proximal and peripheral lung contributions to inflammation, with a particular interest for the alveolar lung zone and its implication on airway function. Objective: We aimed to isolate the acinar lung zone contribution to both inflammation and airway function to seek a relationship between them. Methods: In 30 patients with asthma with an asthma control test score exceeding 20, indices of conductive and acinar ventilation heterogeneity (Scond, Sacin) were obtained from a multiple breath washout. NO production in the conductive airways (J'aw(NO)), alveolar NO concentration (CA(NO)), and the standard exhaled NO at 50 mL/s (FENO50) were obtained from exhaled NO. Results: Scond was consistently abnormal in all patients with stable asthma, but without any correlation to inflammation abnormality in that compartment (J'aw(NO)). Sacin was particularly abnormal in the asthma subgroup receiving >500 mu g budesonide equivalent, and a correlation was found between Sacin and CAN (r = 0.61; P = .015); in this subgroup, a weak association was found between Scond and J'aw(NO) or FENO50 (r = 0.50; P = .059 for both). Conclusion: The persistent functional abnormality of small conductive airways in patients with stable asthma is largely independent of inflammation as measured by exhaled NO. In the alveolar compartment, a functional correlate of alveolar NO was found in a subgroup of patients with stable asthma on moderate-to-high maintenance doses of inhaled steroids. These patients in particular could benefit from novel therapies specifically aimed at improving airway functionality at the level of the acinar entrance and beyond. (J Allergy Clin Immunol 2010;125:611-6.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available